U.S. Metagenomics Market (2024 - 2030) Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, And Segment Forecasts

Table of Contents

Chapter 1. Methodology And Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                        1.2.1. Product
                        1.2.2. Technology
                        1.2.3. Workflow
                        1.2.4. Application
                    1.3. Information analysis
                    1.4. Market formulation & data visualization
                    1.5. Data validation & publishing
                    1.6. Information Procurement
                        1.6.1. Primary Research
                    1.7. Information or Data Analysis
                    1.8. Market Formulation & Validation
                    1.9. Market Model
                    1.10. Objectives
Chapter 2. U.S. Metagenomics Market: Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Metagenomics Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Drivers Analysis
                            3.2.1.1. Declining expenses of sequencing
                            3.2.1.2. Development in biotechnology & bioinformatics techniques
                            3.2.1.3. Rising interest in microbial screening for different investigations
                            3.2.1.4. Emergence of new fields in genomics that complement metagenomics.
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Limited accessibility to computation and different analytic tools
                            3.2.2.2. High overall cost of metagenomics
                    3.3. Industry Analysis Tools
                        3.3.1. Porter's Five Forces Analysis
                        3.3.2. PESTEL Analysis
                        3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Metagenomics Market: Product Business Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Metagenomics Market Product Movement Analysis
                    4.3. U.S. Metagenomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
                        4.3.1. Kits and Reagents
                            4.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        4.3.2. Sequencing & Data Analytics Services
                            4.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        4.3.3. Software
                            4.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 5. U.S. Metagenomics Market: Technology Business Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Metagenomics Market Technology Movement Analysis
                    5.3. U.S. Metagenomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
                        5.3.1. Shotgun Sequencing
                            5.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        5.3.2. 16S Sequencing
                            5.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        5.3.3. Whole Genome Sequencing
                            5.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        5.3.4. Others
                            5.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 6. U.S. Metagenomics Market: Workflow Business Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Metagenomics Market Workflow Movement Analysis
                    6.3. U.S. Metagenomics Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
                        6.3.1. Pre-sequencing
                            6.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        6.3.2. Sequencing
                            6.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        6.3.3. Data Analysis
                            6.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 7. U.S. Metagenomics Market: Application Business Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Metagenomics Market Application Movement Analysis
                    7.3. U.S. Metagenomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                        7.3.1. Environmental
                            7.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        7.3.2. Clinical Diagnostics
                            7.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        7.3.3. Drug Discovery
                            7.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        7.3.4. Biotechnology
                            7.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        7.3.5. Food & nutrition
                            7.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
                        7.3.6. Others
                            7.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Participant Categorization
                    8.2. Strategy Mapping
                    8.3. Company Market Position Analysis, 2023
                    8.4. Participant’s Overview
                        8.4.1. Bio-Rad Laboratories, Inc.
                            8.4.1.1. Overview
                            8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.1.3. Product Benchmarking
                            8.4.1.4. Strategic Initiatives
                        8.4.2. Illumina, Inc.
                            8.4.2.1. Overview
                            8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.2.3. Product Benchmarking
                            8.4.2.4. Strategic Initiatives
                        8.4.3. PerkinElmer, Inc
                            8.4.3.1. Overview
                            8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.3.3. Product Benchmarking
                            8.4.3.4. Strategic Initiatives
                        8.4.4. Thermo Fisher Scientific, Inc
                            8.4.4.1. Overview
                            8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.4.3. Product Benchmarking
                            8.4.4.4. Strategic Initiatives
                        8.4.5. Novogene Co., Ltd.
                            8.4.5.1. Overview
                            8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.5.3. Product Benchmarking
                            8.4.5.4. Strategic Initiatives
                        8.4.6. Promega Corporation
                            8.4.6.1. Overview
                            8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.6.3. Product Benchmarking
                            8.4.6.4. Strategic Initiatives
                        8.4.7. QIAGEN
                            8.4.7.1. Overview
                            8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.7.3. Product Benchmarking
                            8.4.7.4. Strategic Initiatives
                        8.4.8. Takara Bio, Inc.
                            8.4.8.1. Overview
                            8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.8.3. Product Benchmarking
                            8.4.8.4. Strategic Initiatives
                        8.4.9. Oxford Nanopore Technologies plc.
                            8.4.9.1. Overview
                            8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.9.3. Product Benchmarking
                            8.4.9.4. Strategic Initiatives
                        8.4.10. F. Hoffmann-La Roche Ltd.
                            8.4.10.1. Overview
                            8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            8.4.10.3. Product Benchmarking
                            8.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Metagenomics Market, By Product, 2018 - 2030 (USD Million)
Table 4 U.S. Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
Table 5 U.S. Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
Table 6 U.S. Metagenomics Market, By Application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Metagenomics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook
Fig. 13 Sexual health supplements market driver analysis
Fig. 14 Metagenomics market restraint analysis
Fig. 15 Metagenomics market: Porter's analysis
Fig. 16 Metagenomics market: PESTEL analysis
Fig. 17 Metagenomics market: Technology outlook and key takeaways
Fig. 18 Metagenomics market: Technology market share analysis, 2023 - 2030
Fig. 19 U.S. metagenomics by shotgun sequencing market, 2018 - 2030 (USD Million)
Fig. 20 U.S. metagenomics by 16S sequencing market, 2018 - 2030 (USD Million)
Fig. 21 U.S. metagenomics by whole genome sequencing market, 2018 - 2030 (USD Million)
Fig. 22 U.S. metagenomics by others market, 2018 - 2030 (USD Million)
Fig. 23 Metagenomics market: Product outlook and key takeaways
Fig. 24 Metagenomics market: Product market share analysis, 2023 - 2030
Fig. 25 U.S. metagenomics by kits & reagents market, 2018 - 2030 (USD Million)
Fig. 26 U.S. metagenomics by sequencing & data analytics services market, 2018 - 2030 (USD Million)
Fig. 27 U.S. metagenomics by software market, 2018 - 2030 (USD Million)
Fig. 28 Metagenomics market: Application outlook and key takeaways
Fig. 29 Metagenomics market: Application market share analysis, g
Fig. 30 U.S. metagenomics by environmental market, 2018 - 2030 (USD Million)
Fig. 31 U.S. metagenomics by clinical diagnostics market, 2018 - 2030 (USD Million)
Fig. 32 U.S. metagenomics by drug discovery market, 2018 - 2030 (USD Million)
Fig. 33 U.S. metagenomics by biotechnology market, 2018 - 2030 (USD Million)
Fig. 34 U.S. metagenomics by food & nutrition market, 2018 - 2030 (USD Million)
Fig. 35 U.S. metagenomics by others market, 2018 - 2030 (USD Million)
Fig. 36 Metagenomics market: Workflow outlook and key takeaways
Fig. 37 Metagenomics market: Workflow market share analysis, 2023 - 2030
Fig. 38 U.S. metagenomics by pre-sequencing market, 2018 - 2030 (USD Million)
Fig. 39 U.S. metagenomics by sequencing market, 2018 - 2030 (USD Million)
Fig. 40 U.S. metagenomics by data analysis market, 2018 - 2030 (USD Million)
Fig. 41 Key company categorization
Fig. 42 Company market positioning
Fig. 43 Market participant categorization
Fig. 44 Strategy framework